21.	Supplemental data

The following information is presented as supplemental data as required by the indentures governing the Company’s senior notes.

Condensed Consolidating Statements of Income

										Company and
	Consolidated			Physician			Unrestricted			Restricted
For the three months ended March 31, 2016	Total			Groups			Subsidiaries			Subsidiaries⁽¹⁾
Patient service operating revenues	$	2,477,738		$	62,692		$	—		$	2,415,046
Less: Provision for uncollectible accounts		(109,205	)		(2,093	)		—			(107,112	)
Net patient service operating revenues		2,368,533			60,599			—			2,307,934
Capitated revenues		887,047			398,429			—			488,618
Other revenues		325,556			7,573			—			317,983
Total net operating revenues		3,581,136			466,601			—			3,114,535
Operating expenses		3,216,247			468,588			(158	)		2,747,817
Operating income		364,889			(1,987	)		158			366,718
Debt expense, including refinancing charges		(102,884	)		(3,740	)		—			(99,144	)
Other income		2,976			155			—			2,821
Income tax expense		126,822			11,295			63			115,464
Net income		138,159			(16,867	)		95			154,931
Less: Net income attributable to noncontrolling interests		(40,725	)		—			—			(40,725	)
Net income attributable to DaVita HealthCare Partners Inc.	$	97,434		$	(16,867	)	$	95		$	114,206

⁽¹⁾	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Comprehensive Income

									Company and
	Consolidated			Physician			Unrestricted		Restricted
For the three months ended March 31, 2016	Total			Groups			Subsidiaries		Subsidiaries⁽¹⁾
Net income	$	138,159		$	(16,867	)	$	95	$	154,931
Other comprehensive loss		6,313			—			—		6,313
Total comprehensive income		144,472			(16,867	)		95		161,244
Less: comprehensive loss attributable to the noncontrolling interests		(40,725	)		—			—		(40,725	)
Comprehensive income attributable to DaVita HealthCare Partners Inc.	$	103,747		$	(16,867	)	$	95	$	120,519

⁽¹⁾	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Balance Sheets

							Company and
	Consolidated		Physician		Unrestricted		Restricted
As of March 31, 2016	Total		Groups		Subsidiaries		Subsidiaries⁽¹⁾
Cash and cash equivalents	$	1,041,427	$	143,953	$	—	$	897,474
Accounts receivable, net		1,855,285		435,688		—		1,419,597
Other current assets		1,302,848		22,287		—		1,280,561
Total current assets		4,199,560		601,928		—		3,597,632
Property and equipment, net		2,911,205		1,678		—		2,909,527
Amortizable intangibles, net		1,678,707		5,656		—		1,673,051
Other long-term assets		239,098		74,692		2,982		161,424
Goodwill		9,485,628		16,234		—		9,469,394
Total assets	$	18,514,198	$	700,188	$	2,982	$	17,811,028
Current liabilities	$	2,443,618	$	255,174	$	—	$	2,188,444
Payables to parent		—		343,657		2,982		(346,639	)
Long-term debt and other long-term liabilities		10,236,143		49,705		—		10,186,438
Noncontrolling interests subject to put provisions		912,705		—		—		912,705
Total DaVita HealthCare Partners Inc. shareholders’ equity		4,703,926		51,652		—		4,652,274
Noncontrolling interests not subject to put provisions		217,806		—		—		217,806
Shareholders’ equity		4,921,732		51,652		—		4,870,080
Total liabilities and shareholder’s equity	$	18,514,198	$	700,188	$	2,982	$	17,811,028

⁽¹⁾	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Cash Flows

										Company and
	Consolidated			Physician			Unrestricted			Restricted
For the three months ended March 31, 2016	Total			Groups			Subsidiaries			Subsidiaries⁽¹⁾
Cash flows from operating activities:
Net income	$	138,159		$	(16,867	)	$	95		$	154,931
Changes in operating and intercompany assets and liabilities and non-cash items included in net income		290,843			(64,656	)		(95	)		355,594
Net cash provided by (used in) operating activities		429,002			(81,523	)		—			510,525
Cash flows from investing activities:
Additions of property and equipment		(173,187	)		(200	)		—			(172,987	)
Acquisitions and divestitures, net		(405,154	)		—			—			(405,154	)
Proceeds from discontinued operations		4,657			—			—			4,657
Investments and other items		19,373			(536	)		—			19,909
Net cash used in investing activities		(554,311	)		(736	)		—			(553,575	)
Cash flows from financing activities:
Long-term debt		(24,571	)		—			—			(24,571	)
Intercompany		—			137,967			—			(137,967	)
Other items		(308,526	)		—			—			(308,526	)
Net cash (used in) provided by financing activities		(333,097	)		137,967			—			(471,064	)
Effect of exchange rate changes on cash		717			—			—			717
Net increase (decrease) in cash		(457,689	)		55,708			—			(513,397	)
Cash and cash equivalents at beginning of period		1,499,116			88,245			—			1,410,871
Cash and cash equivalents at end of period	$	1,041,427		$	143,953		$	—		$	897,474

⁽¹⁾	After elimination of the unrestricted subsidiaries and the physician groups.